MedPath

Short-term and long-term efficacy and safety evaluation of acupoint catgut embedding in the simple obesity: a randomized controlled double-blind trial

Phase 1
Recruiting
Conditions
simple obesity
Registration Number
ITMCTR2200005494
Lead Sponsor
The Fifth Affiliated Hospital of Southern Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1.Meet the diagnostic criteria for being overweight or obese;
2.Aged 18 to 60 years;
3.Have not received any other weight-loss treatment within the last 3 months;
4.Volunteered to participate in the study and signed the informed consent.

Exclusion Criteria

1.Allergic to alcohol or PGLA;
2.Pregnant or lactation patients;
3.Secondary obesity, as follows thalamus, pituitary disease, hypothyroidism, increased cortisol, increased insulin, changes in gonadal secretion and drugs caused by secondary obesity patients;
4.Complicated with serious cardiovascular and cerebrovascular diseases, liver and kidney diseases, mental or emotional disorders unable to cooperate;Local skin damage or infection;
5.Patients with abnormal coagulation function.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.